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ABSTRACT
The Escherichia colifadR gene is a multifunctional regulator of fatty acid
and acetate metabolism. In the present work the nucleotide sequence of the
1.3 kb DNA fragment which encodes FadR has been determined. The coding
sequence of the fadR gene is 714 nucleotides long and is preceded by a typical
E. coli ribosome binding site and is followed by a sequence predicted to be
sufficient for factor-independent chain termination. Primer extension experi-
ments demonstrated that the transcription of thefadR gene initiates with an
adenine nucleotide 33 nucleotides upstream from the predicted start of
translation. The derived fadR peptide has a calculated molecular weight of
26,972. This is in reasonable agreement with the apparent molecular weight
of 29,000 previously estimated on the basis of maxi-cell analysis of plasmid
encoded proteins. There is a segment of twenty amino acids within the
predicted peptide which resembles the DNA recognition and binding site of
many transcriptional regulatory proteins.
INTRODUCTION
Upon growth of E. colt cells in minimal medium containing long-chain
fatty acids (C 12-C 18: 1) the products of the fadL (50 min), fadD (24 min), fadE
(5 min), fadAB (85 min) and aceBAK (90 min) genes and operons are coordi-
nately induced (reviewed in reference 1). These hydrophobic compounds
enter the cell by a protein-mediated translocation step involving the products
of at least the fadL and fadD genes (2,3,4). The product of thefadL gene is
located on the outer membrane where it appears to act as a receptor for long-
chain fatty acids (5). ThefadD gene encodes fatty acyl-CoA synthetase (6). Due
to the coupled transport and activation processes, the main pool of long-chain
fatty acids within the cell is in the form of fatty acyl-CoA rather than free fatty
acids(7). The fatty acyl-CoAs (06-C18: 1) may be degraded via l3-oxidation and
thiolytic cleavage or may be converted to phosphatidic acid to be incorporated
directly into phospholipids (8). At least six additional enzyme activities (the
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products of the fadE, fadA, andfadB genes) are required to carry out these
reactions which result in the release of one molecule of acetyl-CoA for each
turn of the cycle (6-1 1).
Acetyl-CoA produced by 13-oxidation of fatty acids can serve as a substrate
for de novo synthesis of fatty acids and phospholipids or can be metabolized via
the tricarboxylic acid cycle to serve as a carbon and energy source (12). Growth
on fatty acids or acetate as a sole carbon and energy source also requires the
enzymes of the glyoxylate shunt which are encoded within the aceBAK operon
(13,14). These enzymes allow the net assimilation of carbon from acetyl-CoA to
replenish the dicarboxylic acids necessary for the biosynthesis of cellular com-
ponents. The biosynthesis of fatty acids occurs by the condensation of
acetyl-CoA with malonyl- CoA and subsequent chain elongation by the repeated
addition of malonyl-CoA by the fatty acid synthetase complex and acyl carrier
protein to form a -3-keto fatty acid derivative (8). The fatty acids derived by de
novo synthesis may be incorporated into phospholipids, glycolipids and lipo-
proteins (8). Thus the enzymatic pathways of fatty acid degradation, acetate
degradation and fatty acid biosynthesis are linked biochemically through
several common intermediates including acetyl-CoA.
In addition to the biochemical links detailed above, fatty acid degradation
fatty acid biosynthesis and acetate metabolism are coordinately regulated in E.
coli by the product of thefadR gene, FadR (6). In fact, the FadR system
appears to form a global control network as described by Gottesman for the
cAMP-CRP system, the SOS system and the proteins involved in the heat shock
response (15). Spontaneous mutations infadR cause the constitutive expres-
sion of the fad structural genes. These mutants are isolated at a fequency of
1/ 106 by growth on minimal medium containing medium chain fatty acids as
the sole carbon and energy source and map to 25.5 minutes on the E. coli
genetic map (6,16). Medium-chain fatty acids are degraded by the same
enzymatic machinery as long-chain fatty acids but do not serve as a carbon
source. Transposon insertions infadR which cause highly polar effects and
abolish gene expression also result in constitutive levels of the fadL, fadD, fadE,
fadAB and aceBAK enzymes (1, 17, 18). fadR+ supplied in trans on a F' epi-
some (26) or a plasmid (1) is dominant to the mutantfadR in restoring the
inducible phenotype to the mutant strain. This information suggests thatfadR
is a negative regulator of the fad and ace regulon and that a long-chain fatty acid
or a long-chain fatty acid derivative is the inducer.
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Further evidence suggesting thatfadR controls the fad and ace genes at
the level of transcription was provided by studies using operon fusions which
place the structural gene forB3-galactosidase, lacIZ under the control of the fad
or ace regulatory regions and promoters. fadR strains harboring (fadL-ac
(20), D(fadE-lacZ (19, 21), c(fadAB-1aZ (21), O(aceB-lacZ (22), or
b(aceA-lacZ) (22) have elevated levels of B-galactosidase activity as compared
withfadRf strains whether or not long chain-fatty acids (and/or acetate in the
case of ace-lacZ fusions) are present in the growth medium. fadR+ strains
harboring the fusions have inducible levels of13-galactosidase. Therefore, FadR
appears to be a trans- acting protein which controls fatty acid degradation and
acetate degradation by decreasing the expression of thefad and ace structural
genes. The regulation of the ace genes also involves the gene iciR. Strains
carrying the ace-lacZ fusions and a mutation in icIR have elevated levels of
13-galactosidase (22). Strains which carry both mutations, fadR and iIcR, have
J3-galactosidase levels higher than strains with either mutation alone implying
these regulators have an independent and additive effect (18, 22). Therefore,
transcriptional control of acetate metabolism by FadR and IclR is predicted to
be complex.
The role of FadR in fatty acid biosynthesis is less well defined than its
established role in the control of transcription of thefad and ace genes.
Strains which carry a mutation infadR are elongated as compared to wild-type
strains when grown under conditions which favor rapid growth (ie. LB at 370C)
(23). The fadR cells often fail to septate and long filaments are formed. This
morphological abnormality, which resembles that of thefts and env mutants
(24), is accompanied by a change in the phospholipid composition. fadR mut-
ants synthesize significantly less unsaturated fatty acids than do wild-type cells
(25). This alteration is phenotypically asymptomatic unless thefadR strain also
carries a lesion infabA, the structural gene for 13-hydroxydecanoyl-thioester
dehydrase (26, 27). This enzyme adds the cis-double bond at the C1i:O stage
to the elongating fatty acid chain and is required for unsaturated fatty acid bio-
synthesis. Unlike fadRl fabA(Ts) mutants, fadRfabA(Ts) strains synthesize
insufficient levels of unsaturated fatty acids to sustain growth at both low and
high temperatures and require unsaturated fatty acid supplementation at all
temperatures (27). The affect of a mutation infadR on fatty acid levels is not a
result of increased .0-oxidation due to constitutive levels of thefad enzymes
since mutations in the fad structural genes do not alleviate these affects (fadD,
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fadE andfadAB were tested (27)). These results suggest thatfadR positively
regulates unsaturated fatty acid biosynthesis at the level offabA expression.
However, the pleiotropic affects offadR on phospholipid and unsaturated fatty
acid biosynthesis may be an indirect result of modulation by a secondary
effector(s) itself controlled byfadR+. We cannot distinguish between these
possibilities at this time.
To further define the role offadR in the regulation of these fatty acid and
lipid-related pathways, we have previously cloned and preliminarily character-
izedfadR (19). A single polypeptide (29,000Mr) specifically associated with
wild-type fadR gene activity was identified by maxi-cell analysis of plasmid
encoded proteins (19). In this work, I present the complete nucleotide se-
quence of thefadR gene and mapping of the transcription initiation site. A
single open reading frame capable of encodingfadR was derived from the DNA
sequence. This derived protein sequence is believed on the basis of the trans-
cription analysis and deletion analysis to be thefadR peptide sequence.
MEiIODS
Bacterial strains and Media.
The E. coli host JM103 was used for M13 propagation (28). Methods of
phage growth and DNA isolation were as described by J. Messing (28).
For analysis of thefadR phenotype strain LS1085 (fadR: :Tnl 0 (19)) was
transformed with the plasmid of interest using standard CaC12 treatment
procedures(29). Transformants were selected on solid LB medium (30) con-
taining ~lOOg/ml ampicillin. Transformants were stippled to solid medium E
(31) containing 0.0 1% leucine and 0.0 1% threonine and one of the following
carbon sources: 50mM acetate; 5mM oleate in 0.5% Brij 58; or 5mM decanoate
in 0.5% Brij 58. Growth on minimal medium containing decanoate (C1:0) is
indicative of thefadR mutation (6). ThefadR phenotype conferred by these
plasmids was also evaluated by transformation of LS1 155, fadR::Th 1O/
kOfadA-laZ. This strain was generated as folows. The strain DC530 which
carries fadA::Mu d (Ap, lac.Z)(21) was stabilized with XpL209 as described by
Komeda and Ino (32) to generate strain LS1 154. LS1 154 was madefadR::TnlO
by generalized transduction with P1 vir grown on LS538 1(16) with primary
selection for tetracycline resistance encoded within TnlO to give LS1 155.
LS1 155 was transformed with the plasmid of interest as described in the text
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with selection of transformants on MacConkey indicator plates containing 1%
lactose and lOOg/ml ampicillin. Strain LS1 154 (fadR )is white on these
plates while LS1 155 (fadR) is red due to repression of i3-galactosidase activity
of OfadA-lacZ by the trans-acting product of the fadR gene.
Construction of plasmids containing deletions of faLR sequences.
To generate CD1901, the 1.3kb HinDIII-EcoRV fragment of E. coli chromo-
somal DNA carrying the entire fadR gene (19) was cloned into HinDIII-HindlI
restricted M13mpl9 (28). Clones CD1902-1907 as illustrated in Figure 1
carrying progressive deletions were generated by restricting CD1901 with the
endonucleases Sstl and Xbal followed by ExoIII digestion as described by S.
Henikoff (33). The clone CD2001 containing the fadR gene in the opposite
orientation to CDl901 was generated by filling in the HinDIII end of the same
DNA fragment encodingfadR with deoxynucleotides using the Klenow fragment
of DNA polymerase I, ligating this fragment to HindcI restricted M13mp19,
and identification of the clone of interest by the C-test (28). Deletions of
CD2001 (CD2002-CD2007 as illustrated in Figure 1) were generated in the
same manner as those of CD1901.
Determination of nucleotide sequence.
DNA sequence analysis was performed by the dideoxy chain-terminating
method (34). Sequencing reactions were performed using a[32PJ-dATP
(purchased from Dupont-New England Nuclear) and Klenow (purchased from
Bethesda Research Labs) or a[35SI-dATP(purchased from Dupont-New England
Nuclear) and a Sequenase kit (obtained from United States Biochemicals).
Each clone was sequenced 3-6 times. The reactions were displayed on 0.2mm
X 30 cm X 60cm standard sequencing gels (35) which were doubly loaded
over a period of five hours. Electrophoresis was performed at 90-95 watts
(constant power). This resulted in a sequence pattern with at least a 50 base
overlap between clones. Regions of sequence ambiguities which were noted
using Klenow or GC compressions were resolved by using Sequenase and these
gel electrophoresis conditions.
The sequence information was analyzed using programs accessed through
the BIONET system (Intelligenetics, Inc.).
Mapping of the transcription start point of fadR.
The initiation site of transcription was evaluated by extension of afadR-
specific oligonucleotide hybridized to in vivo synthesized K12 mRNA using
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reverse transcriptase. Total in vivo synthesized RNA was isolated from the
fadR+E. coli strain K12 grown in 100 ml LB broth to 0.35 OD550 using hot
phenol (36). For mapping of the 5' end offadR-specific RNA, the oligonucleo-
tide 5'ATTCCAGATACTITCAA 3' complementary to bases 83-99 in Figure 2
was 5'end-labelled using polynucleotide kinase and 'y[32P1-ATP (as detailed in
reference 35) and then mixed with 20Lg of RNA in 20 p11 of buffer containing
250mM KCI and lOmM Tris, pH8.0. The samples were heated to 800C then
rapidly transferred to a heating block set at the indicated hybridization tem-
perature, usually 390C, for at least two hours. The hybridization temperature
was estimated using the formula of Wallace and Miyada (37). After hybridi-
zation, the samples were diluted with 150gl of reverse transcriptase buffer
containing 50mM Tris pH 7.3, 6mM MgC12, 40mM KC1, 2mM each dATP,
dGTP, dCTP, dlTP and 28 units ofAMV reverse transcriptase (purchased from
United States Biochemicals, Inc.). Samples containing 20pg of total yeast tRNA
orfadR+ RNA and primer incubated without reverse transcriptase were used as
controls. Enzymatic extension of the primer was allowed to proceed for 60min
at 370C. Samples were precipitated with ethanol and resuspended in 10j±l of
formamide gel loading solution (34). The products of the primer extension
reactions were displayed on a 60cm sequencing gel. Dideoxy sequencing
reactions were performed on M13 subclone CD1901 using the same oligonu-
cleotide as primer to determine the size of the extended fragment and position
of the initiating nucleotide.
RESULTS AND DISCUSSION
Nucleotide sequence of the fadR gene.
In previous work the fadR gene was cloned on a 1.3kb HinD III-EcoRV frag-
ment (19). This fragment was determined to contain the entirefadR gene
based on the following criteria: fadR strains harboring this clone 1) no longer
were able to grow on medium chain fatty acids as a sole carbon and energy
source; 2) had inducible levels of fatty acid oxidation and enoyl-CoA hydratase;
and 3) had inducible levels ofj3-galactosidase when thefadR strain also carried
the operon fusion k0fad-laZ. Additionally, the cloned fadR gene relieved
the requirement for unsaturated fatty acid supplementation offadRfabAtTs)
strains at temperatures non-restrictive for the fbAtbs) allele. In the present
study, I have determined the nucleotide sequence of the fadR gene using the
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fadR Functon 1 168 249 35o 571 620 736 885 1294
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Figure 1. fadR sequencing strategy. The M13 clones for sequencingfadR
were generated by cloning the 1.3kb DNA fragment encoding FadR into
M13mp19 in both orientations. The series CD2001-CD2007 were
sequenced from the HinDIII site to the EcoRV site as illustrated. The
series CD1901-CD1907 were sequenced from the EcoRV site to the HinDIII
site. The tail of the arrow indicates the position at which the sequencing
initiates using the M13 universal primer. The tip of the arrow indicates the
approximate distance each clone was read. The location of the initiation
codon, the termination codon, and several restriction sites are also
illustrated. To determine whether the deletions disrupted the coding
sequence of FadR, subclones of fadR DNA were derived from the M13
replicative form, cloned into pUC18 or pUC19, and tested for their ability
to conferfadR+ phenotype, +, or not, -, as described in the text. ND, not
determined.
dideoxy-chain terminating method. The HinDIII-EcoRV fragment encoding
fadR was cloned directly into M13mpl9 in both orientations to generate
CD 1901 and CD2001. Each of these clones were used to generate sequential
deletions as described above in Materials and Methods and illustrated in
Figure 1. The complete nucleotide sequence of the 1.3 kb fragment encoding
fadR is presented in Figure 2.
There was determined to be only one large open reading frame (ORF) with-
in this 1294 base pair DNA fragment capable of encoding a polypeptide with a
molecular weight of 26,972. This ORF extends from base pair 34 to base pair
750 (Figure2). There is only one methionine codon, ATG, at the 5'end of this
ORF at base pairs 34-36. A sequence, 5ATGGA 3', which correlates to the
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-130 -120 -110 -100 -90 80 -70
AAGCTTAACG GTCAGGCAGG AGTGAGGCAA GTCTTGATAG TCAGGGGM AGAGATGCGG AAAATGAAGC
-60 -50 -40 -30 -20 -10 +1
CTTGATCCCT TTTTCTTCTT TTTGTCTGCT ATCAGCGTAG TTAGCCCTCT GGTATGATGA GTCCAACTTT
-35 -10 +1
10 20 30 40 50 60
GTTTTGCTGT GTTATGGAAA TCTCACT ATG GTC ATT AAG GCG CM AGC CCG GCG GGT TTC GCG
MET Val le Lys Ala Gin Oar Pro Ala Gly Phe Ala
SD
70 80 90 100 110 120
GM GAG TAC ATT ATT GM AGT ATC TOGMTMC CGC TTC CCT CCC GGG ACT ATT TTG
Glu Glu Tyr lie lie Glu Oar le Trp Asn Asn Arg Pho Pro Pro Gly Thr le Lou
130 140 150 160 170 180
CCC GCA GM CGT GM CTT TCA GM TTA ATTDGC GTA ACG CGT ACT ACG TTA CGT GM
Pro Ala Glu Arg Glu LeuSe r Glu Leu Ile Gly Val Thr Arg Thr Thr Lou Arg Glu
190 200 210 220 230 240
DGT TTA CAD CDT CTG GCA CGA DAT GGC TOG TTG ACC ATT CM CAT GGC CCG ACG
Val LeuGin Arg Leu Ala Arg Asp Gly Trp Leu ThrIleGln His Gly Lys Pro Thr
250 260 270 280 280
MG GTG MTMT TTC TGG GM ACT TCCGGT TTAMT ATC CTT GM ACA CTG GCG CGA
Lys Val Asn Asn Phe Trp Glu ThrSer Gly Leu AsnIle LeuGlu Thr Leu Ala Arg
300 310 320 330 340 350
CTG GAT CAC GM AGTGTG CCG CAG CTT ATTGATMT TTG CTG TCG GTG CGT ACCMT
Leu Asp HisGluSer Val ProGln LeuIle Asp Asn Leu LeuSer Val Arg Thr Asn
360 370 380 390 400 410
ATT TCC ACT ATT TTT ATT CGC ACC GCG TTT CGT CAG CAT CCCGATAMAGCG CAG GM
IleSer ThrIle Phe Ile Arg Thr Ala Phe Arg Gln His Pro Asp Lys AlaGlnGlu
420 430 440 450 460
GTG CTG GCT ACCGCTMT GM GTGGCCGAT CACGCCGATGCC TTTGCC GAG CTG GAT
Val Leu Ala Thr Ala AsnGlu Val Ala Asp His Ala Asp Ala Phe AlaGlu Leu Asp
470 480 490 500 510 520
TAC ACC ATA TTC CGCGGC CTG GCG TTTGCTTCC GGCMC CCG ATT TACGGT CTG ATT
Tyr AsnIle Phe Arg Gly Leu Ala Phe AlaSer Gly Asn ProIle Tyr Gly Leu Ile
530 540 550 560 570 580
CTTMCGGG ATG AM GGG CTG TAT ACG CGT ATTGGT CGT CAC TAT TTCGCCMT CCG
Leu Asn Gly MET Lys Gly Leu Tyr Thr Arg Ile Gly Arg His Tyr Phe Gla Asn Pro
590 600 610 620 630
GM GCG CGC AGT CTG GCG CTGGGC TTC TAC CAC AAA CTG TCG GCG TTG TGC AGT GM
Glu ala Arg Ser Leu Ala Leu Gly Phe Tyr His Lys Le- Ser Ala Leu Cys Ser Glu
640 650 660 670 680 690
GGC GCG CAC GAT CAG GTG TAC GM ACA GTG CGT CGC TAT GGG CAT GAG AGT GGC GAG
Gly Ala His Asp Gln Val Tyr Glu Thr Val Arg Arg Tyr Gly His Glu Ser Gly Glu
700 710 720 730 740 750
ATT TGG CAC CGG ATG CAG MA MT CTG CCG GGT GAT TTA GCC ATT CAG GGG CGA TM
Ile Trp His Arg MET Gln Lys Asn Leu Pro Gly Asp Leu Ala Ile Gln Gly Arg
760 770 780 790 800 810 820
TCCCTTCCGT TTMAGAGCA AACCCCTCM ACGAGGGGTT TTTTGTTGTT TTTACAGATT TCCCATTCTT
830 840 850 860 870 880 890
GGCGGGCMC GTTCCAGCM CTCGATGCTG CCGTCTTCGT TTTGCTGTTC GAGCATCACA TCAAATCCCC
900 910 920 930 940 950 960
ACAGGCGATG CACATGCTTC AGGACTTCTT TGCGCCCCCG ATCCCCTTCG MGGAAAGAC CTGATGCTTT
970 980 990 1000 1010 0020 1030
TCGTDCDCDC ATAAAATACC TTGATACTGT GCCOGATGM AGCOOGTICC GACGAGTAGA TGCMTTATO
1040 1050 1060 1070 1061 1090 1100
GTTTCTCCGC CAAGAATCTC TTTGCATTTA TCMGTGTTT CCTTCA.'TGA TATTCCGAGA GCATCAATAT
1110 1120 1130 1140 1150 1160
DCMTGCTD,T TGGGATGGCA ATTTTTACDC CTOTTTTDCYT TTDCTCGACA TAAACT
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concensus sequence of Shine and Dalgamo (38) for the ribosome binding site
occurs closely upstream. The deduced fadR coding sequence ends with a
termination codon TAA at base pairs 751-753. This region is followed by a
GC-rich region of dyad symmetry (estimated hairpin formation AG= -15.3)
which may be sufficient for factor independent termination (39). No other
regions of extensive dyad symmetry predicted to form stable stem and loop
structures were found.
Previous work employing maxicell analysis had identified a single
polypeptide associated with wild-typefadR gene activity with an apparent
molecular weight of 29,000 as determined by polyacrylamide-sodium dodecyl
sulfate gel electrophoresis (19). This estimation of molecular weight is in
reasonable agreement with the molecular weight predicted from the DNA
sequence to encode thefadR protein (26,954). This ORF encompasses the
HincII (350bp) and the HaeII (736bp) restriction endonuclease cleavage sites
previously shown by subcloning experiments and maxicell analysis to disrupt
fadR gene activity (19). To more narrowly define the facdR coding sequence
and to lend support to the conclusion that this was the correct reading frame, I
subcloned several ExcoIII deletions of CD2001 and CD 1901 by restriction of the
M13 clone of interest with HtnDIII and EcoRl (See Figure 1). These restriction
enzyme cleavage sites lie outside of the insert of E. coli chromosomal DNA in
the polylinker region of M13mp19. The fragments containingfadR sequences
of interest were inserted into pUC18 or pUC 19 such that the predicted fadR
coding sequence was in opposite orientation to the strong lac promoter. The
resulting plasmids incude: pCDl1 0 a subclone of CD2001 containing the entire
1294 base pair sequence; pCDl1 1 a subclone of CD2002 in which bases -134 to
-24 are deleted; pCDl 12 a subclone of CD1903 in which bases +806 to +1160
are deleted; and pCDl 14 a subclone of CD2003 in which bases -134 to +106
are deleted.
The presence offadR+ was evaluated by transforming the plasmid of
interest into fadR::TnlO strain LS1085. Transformants were selected on LB
Figure 2. The complete nucleotide sequence and derived amino acid
sequence of fadR. The transcription initiation site is labeled + 1 and is
delineated by a vertical arrow. The series of nucleotides closest to
concensus for E. colt promoters are underlined and labeled -10 and -35.
The putative ribosome binding site is underlined and labeled SD. The region
of dyad symmetry proposed to be the factor independent transcription
terminator is marked by two convergent arrows.
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plates containing 1OOg/ml ampicillin. ThefadR phenotype of the transform-
ants was evaluated by replica plating to minimal media containing 5mM oleate
(C18: 1) and ampicillin or 5mM decanoate (C 10) and ampicillin. In this case,
cells carrying intactfadR on a plasmid will be able to grow on minimal media
containing oleate but not minimal media containing decanoate. This is because
long- but not medium-chain fatty acids can induce the expression of thefad
enzymes. Inactivation of the negative regulatory gene, fadR, is required for
growth on medium-chain fatty acids. As an additional test for the presence of
fadR+, the plasmids were transformed into strain LS1 155, fadR::Th10/
XbfadA-lacZ, and the transformants were plated on MacConkey indicator
plates containing 1% lactose and lOOjg/ml ampicillin. In thefadA-cZ
fusion, the gene for.13-galactosidase is under the control of thefadA promoter.
Since fadR is inactivated in strain LS1155 due to the presence of the transpo-
son, .B-galactosidase activity is constitutive and the strain was red on the
indicator plates. Transformants harboring plasmids which carryfadRtR were
white on these indicator plates while transformants harboring plasmids with
fad.R deletions or the vector alone were red. Based on these two independent
methods used to characterize thefadR phenotyes, each of the plasmids
constructed above except pCDi 14 carried an intactfadR gene. This is
consistent with the predicted ORF. The only result which was somewhat sur-
prising was that pCD 111 in which 110 bases of the 5' sequences are deleted
also appears fadR+. This deletion therefore extends into the predicted -35
region of thefadR promoter as discussed below. This result may be explained
if the deletion generates a sequence which may act as a promoter forfadR.
Sequencing of CD2002 using a primer complementary to sequences upstream
of the EcoRI site yields the following sequence: 5'-TTGTAAAACGA-N17-
TATGAT-3. This construction maintains the predicted -10 region and yields a
poor -35 region. Since the plasmid pCDi 11 is present in very high copy
number within the cell, this construction may be sufficiently transcribed to
give afadR+ phenotype. Deletions into the predicted coding region as in
clones pCDi 14 described in this work and pACHinci and pACHH8 described
previously (19) do not confer the wild-typefadR phenotype even in the
multicopy condition.
Mapping of the 5'end of fadR mRNA.
The initiation site of transcription was determined using primer extension
analysis. These experiments are described in Materials and Methods. A repre-
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Figure 3. Dete3mination of the site of hadRtranscription initiation by
wrimer extension. AnfadR-specific oligonucleotide was 5' end labeled with
2p, hybridized to RNA isolated from E. coli K12, and extended with
reverse transcriptase as described within the text. Lanes C, T, A and G are
the products of dideoxy sequencing reactions (G, A, T and C respectively)
using the same oligonucleotide as primer and CDe901 as template. In this
experiment samples were hybridized at 39yC (lanes 1, 4 and 5), 42bC (lane
2) or 46eC (lane 3). Lane 4 is the product of the hybridization reaction
without extension (i.e. no reverse transcriptase). Lane 5 is the product of
hybridization and extension of yeast tRNA using the same fadR-specific
primer.
sentative experiment is presented in Figure 3. The most prominent extended
fragment indicates that intitiation occurs with an adenine residue, designated
+1. The primer extension experiments also yielded a less pronounced band at
nucleotide +1 1 which we believe is due to a failure of the enzymatic extension
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through the uridine rich track in this region. The predictedfadR promoter
includes a -10 region, 5TATGAT 3', which nearly matches the concensus
sequence for E. coli promoters (6 out of 7 nucleotides in common). The region
15-19 base pairs upstream from the predicted -10 region corresponds less
well to the consensus -35 region. If one allows an unusually wide spacing of 25
nucleotides the sequence 5ITGTCT'3 shares 4 out of 6 nucleotide identities
in common with the concensus -35 region. The nucleotide sequence in the
-35 region is not as highly conserved as the -10 region in many E. coli genes
(40), particularily promoters which require activators for full expression (41).
The poor homology of the predicted -35 region to the consensus sequence
may indicate thatfadR is regulated by factors as yet undefined. Given the
important role forfadR in regulating many fatty acid-related pathways it would
not be surprising thatfadR expression is itself regulated at the level of
transcription.
Many E. coli genes require catabolite gene activator protein (CAP) and cAMP
for full expression. The sequence of nucleotides between -114 and -90 in
Figure 2 has partial dyad symmetry and shows a number of nucleotide identi-
ties with the binding site of several well-characterized CAP-responsive
promoters. This includes a sequence 5'AGTGA 3' infadR which is similar to
5TGTGA 3' suggested as a CAP concensus recognition sequence (42). While
there is extensive genetic and biochemical evidence that fadR-reponsive genes
of the fad regulon and ace operon are subject to catabolite repression and
require cAMP-CAP for full expression this is the first indication thatfadR might
be subject to similar controls.
Predictions of protein structure from the derived amino acid sequence.
A single large ORF of 239 amino acids is predicted to encode thefadR
protein. The derived amino acid sequence is given in Figure 2. The codon
usage for this polypeptide is similar to the codon usage for moderately ex-
pressed genes (44) including many E. coli regulatory genes (45). There is no
unusual clustering or extensive use of rare codons.
The fadR gene product has been previously characterized by classical
genetic means as a diffusible protein which exerts negative control over fatty
acid degradation and acetate metabolism by decreasing the transcription of
the fad and ace structural genes (1). Many E. coli regulatory proteins which
exert their affects by binding to DNA share amino acid and structural identi-
ties over at least a 20 amino acid segment generally found near the amino
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terminus, termed the helix-turn- helix motif (46-48). Amino acids 34-54 of
thefadR peptide sequence presented in Figure 2 shows reasonable homology
to the helix-turn-helix motif. This segment is: glu34-arg-glu-leu-ser-glu-leu-
ile-gly-val-thr-arg-thr-thr-leu-arg-glu-val-leu-gln53 Structural predictions of
thisfadR peptide segments using the method of Chou and Fasman(49) predict
a-helical segments for amino acids 34-41 (Pa=1. 145; Pj3=0.958) and amino
acids 46-53 (Pa= 1.1 1; P13=1.003) and a 13-sheet segment for amino acids
40-47 (Pa=0.924; P13=1.231). Within the 13-sheet segment is found the highly
conserved glycine residue. Residues 37, 41,43,and 48 are hydrophobic while
residues 34, 35, 36 39, 44, 45, and 47 are hydrophilic in agreement with the
predictions of the model of Pabo and Sauer (46). Analysis of this segment by
the method of Dodd and Egan (50) which estimates the occurence of each
amino acid at each position relative to a master set of DNA-binding domains
yields a low (6%) but significant probability that this peptide segment
resembles the XCro DNA-binding domain. While this peptide sequence com-
parison only suggests a DNA-binding region within thefadR protein, it does
provide a basis on which to design future studies to evaluate whether or not
this segment of thefadR protein in particular is important in regulation of
fadR-responsive genes and if this regulation is mediated by DNA-binding.
The method of Kyte and Doolittle (51) for the analysis of the hydropathic
character of a protein was applied to the ORF predicted to encode fadR. This
analysis predicts thatfadR is a soluble protein. There is only one region with
non-polar character which might predict a membrane spanning region for this
protein (i. e. 20 amino acids or more (52)). It is unclear if this structural pre-
diction reflects actual membrane association.
The DNA and derived amino acid sequences presented in this study will be
used to design future experiments directed toward a detailed characterization
of the fadR gene and protein. The ultimate goal of this work is to describe in
molecular detail the control of the fad, ace and fab genes byfadR. This
regulatory gene modulates these genetically distinct, biochemically
interrelated pathways in a complex manner which is presently poorly
understood.
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